A carregar...
Nilotinib-Induced Acute Pancreatitis in a Patient with Chronic Myeloid Leukemia
Nilotinib, a second-generation tyrosine kinase inhibitor, is used for treatment of chronic myeloid leukemia (CML); it has been widely used especially for imatinib-resistant CML. Despite being a novel drug in this therapeutic class, it has the potential to be harmful. We present the case of an elderl...
Na minha lista:
| Publicado no: | Case Rep Gastroenterol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger AG
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5471777/ https://ncbi.nlm.nih.gov/pubmed/28626381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000468510 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|